Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/195454
Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Objective: Metabolic syndrome is a health-threatening condition suffered by approximately one third of schizophrenia patients and largely attributed to antipsychotic medication. Previous evidence reports a common genetic background of psychotic and metabolic disorders. In this study, we aimed to assess the role of polygenic risk scores (PRSs) on the progression of the metabolic profile in a first-episode psychosis (FEP) cohort. Method: Of the 231 FEP individuals included in the study, 192-220 participants were included in basal analysis and 118-179 in longitudinal 6-month models. Eleven psychopathologic and metabolic PRSs were constructed. Basal and longitudinal PRSs association with metabolic measurements was assessed by statistical analyses. Results: No major association of psychopathological PRSs with the metabolic progression was found. However, high risk individuals for depression and cholesterol-related PRSs reported a higher increase of cholesterol levels during the follow-up (FDR ≤ 0.023 for all analyses). Their effect was comparable to other well-established pharmacological and environmental risk factors (explaining at least 1.2% of total variance). Conclusion: Our findings provide new evidence of the effects of metabolic genetic risk on the development of metabolic dysregulation. The future establishment of genetic profiling tools in clinical procedures could enable practitioners to better personalize antipsychotic treatment selection and dosage.
Matèries (anglès)
Citació
Citació
SEGURA, Alex g., MARTÍNEZ PINTEÑO, Albert, GASSÓ ASTORGA, Patricia, RODRÍGUEZ FERRET, Natalia, BIOQUE ALCÁZAR, Miquel, CUESTA, Manuel j., GONZÁLEZ PEÑAS, Javier, GARCÍA RIZO, Clemente, LOBO, Antonio, GONZÁLEZ-PINTO, Ana, GARCÍA ALCÓN, Alicia, ROLDÁN, Alexandra, VIETA I PASCUAL, Eduard, CASTRO FORNIELES, Josefina, MANÉ SANTACANA, Anna, SAIZ RUIZ, Jerónimo, BERNARDO ARROYO, Miquel, MAS HERRERO, Sergi, MEZQUIDA MATEOS, Gisela, PEPs Group. Metabolic polygenic risk scores effect on antipsychotic-induced metabolic dysregulation: A longitudinal study in a first episode psychosis cohort. _Schizophrenia Research_. 2022. Vol. 244, núm. 101-110. [consulta: 24 de gener de 2026]. ISSN: 0920-9964. [Disponible a: https://hdl.handle.net/2445/195454]